AR222207A1 - Proceso para la preparacion de tabletas tipo matriz con liberacion retardada del agente activo - Google Patents

Proceso para la preparacion de tabletas tipo matriz con liberacion retardada del agente activo

Info

Publication number
AR222207A1
AR222207A1 AR279792A AR27979280A AR222207A1 AR 222207 A1 AR222207 A1 AR 222207A1 AR 279792 A AR279792 A AR 279792A AR 27979280 A AR27979280 A AR 27979280A AR 222207 A1 AR222207 A1 AR 222207A1
Authority
AR
Argentina
Prior art keywords
preparation
active agent
matrix type
delayed release
type tablets
Prior art date
Application number
AR279792A
Other languages
English (en)
Spanish (es)
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of AR222207A1 publication Critical patent/AR222207A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR279792A 1979-02-02 1980-12-30 Proceso para la preparacion de tabletas tipo matriz con liberacion retardada del agente activo AR222207A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne

Publications (1)

Publication Number Publication Date
AR222207A1 true AR222207A1 (es) 1981-04-30

Family

ID=8512353

Family Applications (1)

Application Number Title Priority Date Filing Date
AR279792A AR222207A1 (es) 1979-02-02 1980-12-30 Proceso para la preparacion de tabletas tipo matriz con liberacion retardada del agente activo

Country Status (15)

Country Link
US (1) US4351825A (ja)
EP (1) EP0014514B1 (ja)
JP (1) JPS55129222A (ja)
AR (1) AR222207A1 (ja)
AT (1) ATE20182T1 (ja)
CA (1) CA1144071A (ja)
DE (1) DE3071625D1 (ja)
DK (1) DK28480A (ja)
ES (1) ES488168A0 (ja)
FI (1) FI63335B (ja)
GR (1) GR65623B (ja)
IE (1) IE51741B1 (ja)
NO (1) NO149490B (ja)
PT (1) PT70719A (ja)
ZA (1) ZA80553B (ja)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4927633A (en) * 1984-03-19 1990-05-22 Alza Corporation Dispenser for delivering drug to livestock
US4624945A (en) * 1984-03-19 1986-11-25 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
US6056992A (en) * 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
IL96311A (en) † 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5431630A (en) * 1993-09-07 1995-07-11 Surgic-Acid, Inc. Needle guard and nonreusable syringe
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6776996B2 (en) 1997-07-09 2004-08-17 Basf Aktiengesellschaft Pesticidal matrices
ID20839A (id) * 1997-07-09 1999-03-11 American Cyanamid Co Bahan acuan pestisida berlapis lebih baik, pengolahan pada pembuatannya serta komposisi-komposisi yang terkandung di dalamnya
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
CN1203846C (zh) 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1949890A3 (en) 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
HUP0201626A3 (en) * 1999-06-04 2004-05-28 Alza Corp Mountain View Implantable gel compositions and method of manufacture
US6676966B1 (en) 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
EP1549296A4 (en) * 2002-08-02 2006-08-09 Penwest Pharmaceuticals Co METFORMIN FORMULATIONS WITH DELAYED RELEASE
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
SE353229B (ja) * 1970-06-04 1973-01-29 Haessle Ab
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS6191314A (ja) * 1984-10-12 1986-05-09 Nippon Kokan Kk <Nkk> 取鍋精錬炉による溶鋼の精錬方法

Also Published As

Publication number Publication date
NO794290L (no) 1980-08-05
CA1144071A (en) 1983-04-05
ATE20182T1 (de) 1986-06-15
FI790350A (fi) 1980-08-03
EP0014514A2 (en) 1980-08-20
PT70719A (en) 1980-02-01
GR65623B (en) 1980-10-15
DK28480A (da) 1980-08-03
ES8102702A1 (es) 1981-02-16
ES488168A0 (es) 1981-02-16
US4351825A (en) 1982-09-28
EP0014514B1 (en) 1986-06-04
DE3071625D1 (en) 1986-07-10
JPS55129222A (en) 1980-10-06
IE51741B1 (en) 1987-03-18
FI63335B (fi) 1983-02-28
EP0014514A3 (en) 1981-06-10
ZA80553B (en) 1981-02-25
IE800202L (en) 1980-08-02
NO149490B (no) 1984-01-23

Similar Documents

Publication Publication Date Title
AR222207A1 (es) Proceso para la preparacion de tabletas tipo matriz con liberacion retardada del agente activo
IL57796A0 (en) Pharmaceutical compositions having retarded release of the active substance
AR204629A1 (es) Procedimiento para la elaboracion de medicamentos con cesion retardada de la sustancia activa en el intestino
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
NL149493B (nl) Werkwijze ter bereiding van een therapeutisch preparaat, gevormd preparaat, alsmede werkwijze ter bereiding van de daarbij toe te passen actieve verbindingen.
IT8023628A0 (it) Procedimento per la fabbricazione del silicato sodico.
BR7403339D0 (pt) Dispositivo para liberacao de agente ativo e processo para pooducao do mesmo
BR8000934A (pt) Agente dessulfurnate para injecao
ZA707166B (en) Ureidophenylguanidines,process for their preparation and their fungicidal use
AR220113A1 (es) Composiciones fungicidas que contienen n-benzoilantranilatos como agente activo,procedimiento para prepararlas y nuevos n-benzoilantranilatos de aplicacion en dichas composiciones
SE396010B (sv) Forfarande for framstellning av aktiva emnen innehallande preparat med langvarig verkan i form av tabletter, drageer eller kapslar
CH487921A (fr) Procédé de préparation de nouvelles substances physiologiquement actives
PH10708A (en) Recemic and optically active desoxycinchonine and desoxycinchonidine and process for their preparation
IL37856A0 (en) 1-phenyl-2-cyano-2-methylvinyl-thionophosphoric and thionophosphonic acid esters,their preparation and their use as insecticides and acaricides
MX6499E (es) Procedimiento para la elaboracion de tabletas tipo matriz,con liberacion retardada del principio activo
IT1002520B (it) Agente di distacco per elastomeri
ZA703127B (en) New therapeutically active chemical compounds,and processes for their preparation
CH538883A (it) Macchina per la preparazione di granuli con cessione controllata della sostanza attiva in essi contenuta
FI49514C (fi) Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi.
ES530845A0 (es) Agentes antimicoticos con elevada liberacion del producto activo
IT8024166A0 (it) Preparato di deposito con cessione di sostanza attiva rallentata.
IT938951B (it) Poliisocianati procedimento per la loro preparazione e loro impiego
AR192605A1 (es) Procedimiento para la preparacion de 3-ciclopentil-eter de 7alpha-metil-3,16alpha,17-trihidroxi-delta-estratrienos
NO143795C (no) Kjemisk mellomprodukt for bruk ved fremstilling av terapeutisk aktive 2,6-metan-3-benzazosiner
IL36547A0 (en) Oximino phosphorus containing compounds,their preparation and their use as insecticides and acaricides